Second bivalent booster gets go-ahead

Pfizer’s bivalent COVID-19 vaccine approved for use in Australia, with clinical results showing “superior” response against Omicron strain compared to its original vaccine The TGA has provisionally approved Pfizer’s bivalent COVID-19 vaccine, Comirnaty Original/Omicron BA.1 (tozinameran and riltozinameran) for use as a booster dose in adults 18 years and over. It is the second bivalent